Antibiotics in early life and obesity

Nature Reviews Endocrinology

Volumn 11, Issue 3, 2015, Pages 182-190

  Cox, Laura M ^a   Blaser, Martin J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; PROBIOTIC AGENT;

ADULTHOOD; ANIMAL MODEL; BODY WEIGHT; DRUG EXPOSURE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED PRACTICE; FARM ANIMAL; GROWTH, DEVELOPMENT AND AGING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STUNTING; WEIGHT GAIN; ANIMAL; DRUG EFFECTS; FEMALE; FETOMATERNAL TRANSFUSION; MATERNAL NUTRITION; MICROFLORA; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY;

ANIMALS; ANTI-BACTERIAL AGENTS; BODY WEIGHT; FEMALE; GROWTH AND DEVELOPMENT; HUMANS; MATERNAL-FETAL EXCHANGE; MICROBIOTA; OBESITY; PREGNANCY; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PROBIOTICS;

EID: 84923654518     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2014.210     Document Type: Review

References (89)

1. Costello, E. K., Stagaman, K., Dethlefsen, L., Bohannan, B. J. M. & Relman, D. A. The application of ecological theory toward an understanding of the human microbiome. Science 336, 1255-1262 (2012
2. David, L. A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559-563 (2014
3. Koren, O., et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 150, 470-480 (2012
4. Zeissig, S. & Blumberg, R. S. Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease. Nat. Immunol. 15, 307-310 (2014
5. Yatsunenko, T., et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012
6. Martin, R., et al. Early life: gut microbiota and immune development in infancy. Benef. Microbes 1, 367-382 (2010
7. Kalliomäki, M., Collado, M. C., Salminen, S. & Isolauri, E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 87, 534-538 (2008
8. Rautava, S., Luoto, R., Salminen, S. & Isolauri, E. Microbial contact during pregnancy, intestinal colonization and human disease. Nat. Rev. Gastroenterol. Hepatol. 9, 565-576 (2012
9. Ley, R. E., Lozupone, C. A., Hamady, M., Knight, R. & Gordon, J. I. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat. Rev. Microbiol. 6, 776-788 (2008
10. Seekatz, A. M. & Young, V. B. Clostridium difficile and the microbiota. J. Clin. Invest. 124, 1-8 (2014
11. Bäckhed, F., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718-15723 (2004
12. Turnbaugh, P. J., et al. An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1131 (2006
13. Ley, R. E., et al. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102, 11070-11075 (2005
14. Verani, J. R., McGee, L. & Schrag, S. J. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm. Rep. 59, 1-32 (2010
15. Blaser, M. J. & Falkow, S. What are the consequences of the disappearing human microbiota?. Nat. Rev. Microbiol. 7, 887-894 (2009
16. Stokholm, J., Sevelsted, A., Bonnelykke, K. & Bisgaard, H. Maternal propensity for infections and risk of childhood asthma: a registry-based cohort study. Lancet Respir. Med. 2, 631-637 (2014
17. Broe, A., Pottegård, A., Lamont, R. F., Jørgensen, J. S. & Damkier, P. Increasing use of antibiotics in pregnancy during the period 2000-2010: prevalence, timing, category, and demographics. BJOG 121, 988-996 (2014
18. Vidal, A. C., et al. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int. J. Obes. 37, 907-913 (2013
19. Jepsen, P., et al. A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark. Br. J. Clin. Pharmacol. 55, 216-221 (2003
20. Hicks, L. A., Taylor, T. H. & Hunkler, R. J. U.S. outpatient antibiotic prescribing, 2010. N. Engl. J. Med. 368, 1461-1462 (2013
21. McCaig, L. F., Besser, R. E. & Hughes, J. M. Trends in antimicrobial prescribing rates for children and adolescents. JAMA 287, 3096-3102 (2002
22. Grijalva, C. G., Nuorti, J. & Griffin, M. R. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 302, 758-766 (2009
23. Ternhag, A. & Hellman, J. More on U.S. outpatient antibiotic prescribing, 2010. N. Engl. J. Med. 369, 1175-1176 (2013
24. Hersh, A. L., Jackson, M. A., Hicks, L. A. & American Academy of Pediatrics Committee on Infectious Diseases. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics 132, 1146-1154 (2013
25. Fridkin, S., et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR. Morb. Mortal. Wkly Rep. 63, 194-200 (2014
26. Lee, G. C., et Al. Outpatient Antibiotic Prescribing in the United States: 2000 to 2010. BMC Med. 12, 96 (2014
27. Hersh, A. L., Shapiro, D. J., Pavia, A. T. & Shah, S. S. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics 128, 1053-1061 (2011
28. Gerber, J. S., et al. Variation in antibiotic prescribing across a pediatric primary care network. J. Pediatric Infect. Dis. Soc. http://dx.doi.org/10.1093/jpids/piu086
29. Donoghue, D. J. Antibiotic residues in poultry tissues and eggs: human health concerns?. Poult. Sci. 82, 618-621 (2003
30. Andersson, D. I. & Hughes, D. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 12,465-478 (2014
31. Yang, S. & Carlson, K. Evolution of antibiotic occurrence in a river through pristine, urban and agricultural landscapes. Water Res. 37, 4645-4656 (2003
32. Buzby, J. C. International trade and food safety: economic theory and case studies. United States Department of Agriculture Economic Research Service, [online] http://www.ers.usda.gov/publications/aer-Agricultural-economic-report/aer828.aspx (2003
33. No authors listed] United States National Residue Program for Meat, Poultry, and Egg Products: 2011 Residue Sample Results. [online] http://www.fsis.usda.gov/wps/wcm/connect/f511ad0e-d148-4bec-95c7-22774e731f7c/2011-Red-Book.pdf?MOD=AJPERES (2013
34. Marshall, B. M. & Levy, S. B. Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev. 24, 718-733 (2011
35. Ternak, G. Antibiotics may act as growth/obesity promoters in humans as an inadvertent result of antibiotic pollution?. Med. Hypotheses 64, 14-16 (2005
36. Riley, L. W., Raphael, E. & Faerstein, E. Obesity in the United States-dysbiosis from exposure to low-dose antibiotics?. Front. Public Health 1, 69 (2013
37. National Research Council (US) Committee on Drug Use in Food Animals. The use of drugs in food animals: benefits and risks (National Academies Press (US), 1999
38. No authors listed] New animal drugs and new animal drug combination products administered in or on medicated feed or drinking water of food-producing animals: recommendations for drug sponsors for voluntarily aligning product use conditions with GFI #209 [online], http://www.fda.gov/downloads/animalveterinary/guidancecomplianceenforcement/guidanceforindustry/UCM299624.pdf (2013
39. Nelson, R. FDA action on animal antibiotics could still have loopholes. Lancet Infect. Dis. 14, 376-377 (2014
40. Cordle, M. K. USDA regulation of residues in meat and poultry products. J. Anim. Sci. 66, 413-433 (1988
41. Done, H. Y. & Halden, R. U. Reconnaissance of 47 antibiotics and associated microbial risks in seafood sold in the United States. J. Hazard. Mater. http://dx.doi.org/10.1016/j.jhazmat.2014.08.075
42. Taylor, J. H. & Gordon, W. S. Growth-promoting activity for pigs of inactivated penicillin. Nature 176, 312-313 (1955
43. Jukes, T. H. & Williams, W. L. Nutritional effects of antibiotics. Pharmacol. Rev. 5, 381-420 (1953
44. Gaskins, H. R., Collier, C. T. & Anderson, D. B. Antibiotics as growth promotants: mode of action. Anim. Biotechnol. 13, 29-42 (2002
45. Butaye, P., Devriese, L. & Haesebrouck, F. Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria. Clin. Microbiol. Rev. 16, 175-188 (2003
46. Muir, L. A. Mode of action of exogenous substances on animal growth-An overview. J. Anim. Sci. 61 (Suppl 2), 154-180 (1985
47. Coates, M. E., Fuller, R., Harrison, G. F., Lev, M. & Suffolk, S. F. A comparison of the growth of chicks in the Gustafsson germ-free apparatus and in a conventional environment, with and without dietary supplements of penicillin. Br. J. Nutr. 17, 141-150 (1963
48. Ridaura, V. K., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013
49. Cho, I., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488, 621-626 (2012
50. Cox, L. M., et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158, 705-721 (2014
51. Dubos, R., Schaedler, R. W. & Costello, R. L. The effect of antibacterial drugs on the weight of mice. J. Exp. Med. 117, 245-257 (1963
52. Cani, P. D., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481 (2008
53. Vijay-Kumar, M., et al. Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-like Receptor 5. Science 328, 228-231 (2010
54. Henao-Mejia, J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185 (2012
55. Cox, L. M. & Blaser, M. J. Pathways in microbe-induced obesity. Cell Metab. 17, 883-894 (2013
56. Ivanov, I. I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009
57. Jiang, H. Q., Bos, N. A. & Cebra, J. J. Timing, localization, and persistence of colonization by segmented filamentous bacteria in the neonatal mouse gut depend on immune status of mothers and pups. Infect. Immun. 69, 3611-3617 (2001
58. Yin, Y., et al. Comparative analysis of the distribution of segmented filamentous bacteria in humans, mice and chickens. ISME J. 7, 615-621 (2012
59. Davis, C. P. & Savage, D. C. Effect of penicillin on the succession, attachment, and morphology of segmented, filamentous microbes in the murine small bowel. Infect. Immun. 13, 180-188 (1976
60. Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268-1273 (2012
61. Atarashi, K., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011
62. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118 (2005
63. Rune, I., et al. Ampicillin-improved glucose tolerance in diet-induced obese C57BL/6N Tac mice is age dependent. J. Diabetes Res. 2013, 1-13 (2013
64. Carvalho, B. M., et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 55, 2823-2834 (2012
65. Membrez, M., et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 22, 2416-2426 (2008
66. Murphy, E. F., et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62, 220-226 (2013
67. Morel, F. B., et al. Can. Antibiotic treatment in preweaning rats alter body composition in adulthood?. Neonatology 103, 182-189 (2013
68. Bäckhed, F., Manchester, J. K., Semenkovich, C. F. & Gordon, J. I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. USA 104, 979-984 (2007
69. Rabot, S., et al. Germ-free C57BL/6J mice are resistant to high fat diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J. 24, 4948-4959 (2010
70. Fleissner, C. K., et al. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104, 919-929 (2010
71. Ajslev, T. A., Andersen, C. S., Gamborg, M., Sørensen, T. I. A. & Jess, T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int. J. Obes. 35, 522-529 (2011
72. Trasande, L., et al. Infant antibiotic exposures and early-life body mass. Int. J. Obes. 37, 16-23 (2013
73. Azad, M. B., Bridgman, S. L., Becker, A. B. & Kozyrskyj, A. L. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int. J. Obes. 38, 1290-1298 (2014
74. Bailey, L. C., et al. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 168, 1063-1069 (2014
75. Murphy, R., et al. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. Int. J. Obes. 38, 115-119 (2013
76. Blustein, J., et al. Association of caesarean delivery with child adiposity from age 6 weeks to 15 years. Int. J. Obes. 37, 900-906 (2013
77. Huh, S. Y., et al. Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study. Arch. Dis. Child. 97, 610-616 (2012
78. Luoto, R., Kalliomäki, M., Laitinen, K. & Isolauri, E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int. J. Obes. 34, 1531-1537 (2010
79. Angelakis, E., Merhej, V. & Raoult, D. Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect. Dis. 13, 889-899 (2013
80. Hill, C., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506-514 (2014
81. Huovinen, P. Bacteriotherapy: the time has come. BMJ 323, 353-354 (2001
82. Dominguez-Bello, M. G., Blaser, M. J., Ley, R. E. & Knight, R. Development of the human gastrointestinal microbiota and insights from high-Throughput sequencing. Gastroenterol. 140, 1713-1719 (2011
83. Dethlefsen, L., Huse, S., Sogin, M. L. & Relman, D. A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6, e280 (2008
84. Paine, R. T., Tegner, M. J. & Johnson, E. A. Compounded perturbations yield ecological surprises. Ecosystems 1, 535-545 (1998
85. Stokholm, J., et al. Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin. Microbiol. Infect. 20, 629-635 (2014
86. Matamoros, S., Gras-Leguen, C., Le Vacon, F., Potel, G. & de La Cochetiere, M. F. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol. 21, 167-173 (2013
87. Dominguez-Bello, M. G., et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107, 11971-11975 (2010
88. Dubos, R., Schaedler, R. W. & Stephens, M. The effect of antibacterial drugs on the fecal flora of mice. J. Exp. Med. 117, 231-243 (1963
89. Jain, N. & Walker, W. A. Diet and host-microbial crosstalk in postnatal intestinal immune homeostasis. Nat. Rev. Gastroenterol. Hepatol. http://dx.doi.org/10.1038/nrgastro.2014.153